Nifedipene in the Treatment of Blood Pressure Rise After ECT.
Academic Article
Overview
abstract
Extreme rise of blood pressure may increase the risk associated with electroconvulsive therapy (ECT) in patients with cardiovascular disease, cerebrovascular disease, and aortic and intracranial aneurysms. A case is presented in which sublingual nifedipene was used in the treatment of a high-risk patient with severe rise of blood pressure. The therapeutic alternatives of managing severe ECT-related blood pressure increases are presented.
